Diprivan is a brand name of propofol, approved by the FDA in the following formulation(s):
DIPRIVAN (propofol - injectable; injection)
Manufacturer: APP PHARMS
Approval date: June 11, 1996
Strength(s): 10MG/ML [RLD][AB]
Has a generic version of Diprivan been approved?
A generic version of Diprivan has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Diprivan and have been approved by the FDA:
propofol injectable; injection
Manufacturer: HOSPIRA
Approval date: March 17, 2006
Strength(s): 10MG/ML [AB]
Manufacturer: TEVA PARENTERAL
Approval date: January 4, 1999
Strength(s): 10MG/ML [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Diprivan. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Propofol compostion containing edetate
Patent 5,714,520
Issued: February 3, 1998
Inventor(s): Jones; Christopher Buchan & Platt; John Henry
Assignee(s): Zeneca Limited
Sterile pharmaceutical compositions for parenteral administration containing 2,6-diisopropylphenol (propofol) are described for use as anesthetics. The compositions comprise an oil-in-water emulsion of propofol additionally containing a amount of edetate sufficient to prevent significant growth of microorganisms for at least 24 hours after adventitious, extrinsic contamination.Patent expiration dates:
- March 22, 2015
- September 22, 2015✓
- March 22, 2015
Pharmaceutical compositions of propofol and edetate
Patent 5,731,355
Issued: March 24, 1998
Inventor(s): Jones; Christopher Buchan & Platt; John Henry
Assignee(s): Zeneca Limited
Pharmaceutical compositions containing 2,6-diisopropylphenol (propofol) are described for use as anaesthetics. A method for their preparation is described, as their use in producing anaesthesia including induction and maintenance of general anaesthesia and sedation.Patent expiration dates:
- March 22, 2015✓
- September 22, 2015✓✓
- March 22, 2015
Pharmaceutical compositions of propofol and edetate
Patent 5,731,356
Issued: March 24, 1998
Inventor(s): Jones; Christopher Buchan & Platt; John Henry
Assignee(s): Zeneca Limited
Pharmaceutical compositions containing 2,6-diisopropylphenol (propofol) are described for use as anaesthetics. A method for their preparation is described, as their use in producing anaesthesia including induction and maintenance of general anaesthesia and sedation.Patent expiration dates:
- March 22, 2015✓
- September 22, 2015✓✓
- March 22, 2015
Propofol compositions containing edetate
Patent 5,908,869
Issued: June 1, 1999
Inventor(s): Jones; Christopher Buchan & Platt; John Henry
Assignee(s): Zeneca Limited
Pharmaceutical compositions containing 2,6-diisopropylphenol (propofol) are described for use as anaesthetics. A method for their preparation is described, as their use in producing anaesthesia including induction and maintenance of general anaesthesia and sedation.Patent expiration dates:
- March 22, 2015✓
- September 22, 2015✓✓
- March 22, 2015
See also...
- Diprivan Consumer Information (Drugs.com)
- Diprivan Consumer Information (Wolters Kluwer)
- Diprivan Consumer Information (Cerner Multum)
- Diprivan AHFS DI Monographs (ASHP)
- Propofol Consumer Information (Drugs.com)
- Propofol Consumer Information (Wolters Kluwer)
- Propofol Consumer Information (Cerner Multum)
- Propofol AHFS DI Monographs (ASHP)
No comments:
Post a Comment